ADC THERAPEUTICS SA's ticker is ADCT and the CUSIP is H0036K147. A total of 52 filers reported holding ADC THERAPEUTICS SA in Q4 2020. The put-call ratio across all filers is 5.38 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $160,584 | +10.3% | 74,690 | 0.0% | 0.00% | – |
| Q1 2023 | $145,646 | -49.2% | 74,690 | 0.0% | 0.00% | – |
| Q4 2022 | $286,810 | -21.4% | 74,690 | 0.0% | 0.00% | – |
| Q3 2022 | $365,000 | -50.3% | 74,690 | -19.1% | 0.00% | -100.0% |
| Q2 2022 | $734,000 | -45.9% | 92,290 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $1,356,000 | -27.3% | 92,290 | 0.0% | 0.00% | -50.0% |
| Q4 2021 | $1,864,000 | -25.6% | 92,290 | 0.0% | 0.00% | -33.3% |
| Q3 2021 | $2,507,000 | +41.4% | 92,290 | +9.5% | 0.00% | +50.0% |
| Q2 2021 | $1,773,000 | -13.8% | 84,290 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $2,058,000 | +22.5% | 84,290 | +60.6% | 0.00% | 0.0% |
| Q4 2020 | $1,680,000 | – | 52,489 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vantage Consulting Group Inc | 1,186,215 | $5,718,000 | 3.34% |
| Blue Owl Capital Holdings LP | 733,568 | $3,536,000 | 1.53% |
| Redmile Group, LLC | 7,512,029 | $36,208,000 | 1.40% |
| GCM Grosvenor Holdings, LLC | 735,471 | $3,545,000 | 0.84% |
| Prosight Management, LP | 247,630 | $1,194,000 | 0.64% |
| Indie Asset Partners, LLC | 93,839 | $452,000 | 0.46% |
| MPM BioImpact LLC | 334,384 | $1,612,000 | 0.38% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,390,297 | $11,521,000 | 0.23% |
| Eventide Asset Management | 1,879,959 | $9,061,000 | 0.18% |
| APOGEM CAPITAL LLC | 17,405 | $84,000 | 0.08% |